• About Us
    • Overview
    • Education
    • Mission & History
    • Board of Directors
    • The Campus
    • Careers
    • WeizmannNow
  • Our Achievements
    • Overview
    • Cancer
    • Technology
    • Education
    • Our Planet
    • Health & Medicine
    • Physical World
  • Get Involved
    • Overview
    • Partners in Science
    • Estate & Planned Giving
    • Attend an Event
    • Gift Opportunities
  • News & Media
    • Overview
    • News & Media Archive
    • Coronavirus
    • Feature Stories
    • News Releases
    • In The News
    • Video Gallery
    • Ad Campaigns
    • The Weizmann Effect
  • Blog
  • Contact
  • Donate Fighting Coronavirus
Fighting Coronavirus Donate
Fighting Coronavirus Donate
About Us tri
About Us Overview
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
  • WeizmannNow
About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements tri
Our Achievements Overview
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved tri
Get Involved Overview
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media tri
News & Media Overview
  • News & Media Archive
  • Coronavirus
  • Feature Stories
  • News Releases
  • In The News
  • Video Gallery
  • Ad Campaigns
  • The Weizmann Effect
News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog tri
  • The Curiosity Review
Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Contact

Search Results

  • SEARCH BY KEYWORD
  • SEARCH BY TAG
View Articles by Tag:
  • View Articles by Tag
  • Algorithims (5)
  • Alternative energy (23)
  • Alzheimers (44)
  • Archaeology (37)
  • Artificial intelligence (15)
  • Astrophysics (104)
  • Autism (22)
  • Awards (114)
  • Bacteria (101)
  • Behavior (5)
  • Biochemistry (97)
  • Biofuel (7)
  • Biology (303)
  • Biomolecular sciences (2)
  • Blood (41)
  • Brain (172)
  • Cancer (154)
  • Cancer treatment (125)
  • Central nervous system (9)
  • Chemistry (77)
  • Children (3)
  • Circadian clock (1)
  • Climate change (68)
  • Clinical trials (39)
  • Collaborations (11)
  • Community (275)
  • Computers (70)
  • Copaxone (12)
  • Coronavirus (6)
  • Culture (355)
  • Diabetes (32)
  • Earth (68)
  • Education (150)
  • Environment (87)
  • Enzymes (28)
  • Evolution (87)
  • Fertility (17)
  • Fungus (1)
  • Genetics (104)
  • Genomics (2)
  • Heart (4)
  • Heart disease (2)
  • Humanity (80)
  • Immune system (148)
  • Immunology (2)
  • Immunotherapy (34)
  • Inflammation (17)
  • Leadership (106)
  • Leukemia (12)
  • Materials (43)
  • Mathematics (61)
  • Medicine (76)
  • Memory (39)
  • Mental health (56)
  • Metabolism (50)
  • Microbiome (6)
  • Molecular cell biology (3)
  • Molecular genetics (57)
  • Multiple sclerosis (11)
  • Nanoscience (32)
  • Nature (1)
  • Neuroscience (202)
  • Nutrition (71)
  • Optics (29)
  • Organs (9)
  • Parkinsons (10)
  • Personalized medicine (3)
  • Philanthropy (140)
  • Physics (134)
  • Plants (54)
  • Proteins (95)
  • Quantum computer (2)
  • Quantum physics (1)
  • Quantum theory (33)
  • Robots (7)
  • Security (21)
  • Senses (115)
  • Sensors (8)
  • Smoking (1)
  • Solar power (17)
  • Space (105)
  • Stem cells (45)
  • Technology (203)
  • Vaccine (39)
  • Virus (132)
  • Water (39)
  • Weather (1)
  • Women (111)
  • World hunger (16)
Filter by Time:
  • All
  • Past Day
  • Past Week
  • Past Month
  • Past Year
  • Past Three Years
Clear Filters

27 results for Cancer

Cancer Protocols: A New Approach to Predicting Treatment Outcomes
Cancer Protocols: A New Approach to Predicting Treatment Outcomes

https://weizmann-usa.org/news-media/news-releases/cancer-protocols-a-new-approach-to-predicting-treatment-outcomes/

Sep 12, 2019... Prof. Yardena Samuels
REHOVOT, ISRAEL—September 12, 2019—Diversity – at least among cancer cells – is not a good thing. Now, research from the Weizmann Institute of Science shows that in melanoma, tumors with cells that have differentiated into more diverse subtypes are less likely to be affected by the immune system, thus reducing the chance that immunotherapy will be effective. The findings of this research, which were published in Cell, may provide better tools for designing personalized protocols for cancer patients, as well as pointing toward new avenues of research into anti-cancer vaccines.

TAGS: Cancer, Biology, Immunotherapy

A New Route to Blocking Children’s Bone Cancer
A New Route to Blocking Children’s Bone Cancer

https://weizmann-usa.org/news-media/news-releases/a-new-route-to-blocking-children-s-bone-cancer/

Oct 02, 2019... The lungs of a mouse with untreated Ewing sarcoma (left) contain numerous tumor cells (shown by luminescent colors) that have spread from the bone; the lungs of a mouse treated with a drug reducing the synthesis of glucocorticoids are almost free from the sarcoma (right)
REHOVOT, ISRAEL—October 2, 2019—Ewing sarcoma is a bone cancer that appears mainly in teenagers. Caused by a single defective gene, once it spreads to distant organs it is hard to treat. Researchers at the Weizmann Institute of Science have now discovered molecular interactions underlying Ewing sarcomas and proposed a potential treatment that has shown promise in a study in mice. These findings were published in Cell Reports.

TAGS: Cancer, Biology, Cancer treatment, Proteins

Israeli-U.S. Research Finds Brain Cancer Cells Change State
Israeli-U.S. Research Finds Brain Cancer Cells Change State

https://weizmann-usa.org/news-media/in-the-news/israeli-u-s-research-finds-brain-cancer-cells-change-states/

Sep 23, 2019... JERUSALEM, Sept. 23 (Xinhua) – Israeli and U.S. researchers found that glioblastoma brain cancer cells come in four states and can transition from one state to another, the Weizmann Institute of Science (WIS) in central Israel reported on Monday.
The study, published in the journal Cell, was led by researchers from WIS, Massachusetts General Hospital (MGH) in Boston and the Salk Institute for Biological Studies in La Jolla, California.

TAGS: Brain, Cancer

Revolutionary Advances in Cancer Treatment: Memorial Sloan Kettering Cancer Center and the Weizmann Institute of Science
Revolutionary Advances in Cancer Treatment: Memorial Sloan Kettering Cancer Center and the Weizmann Institute of Science

https://weizmann-usa.org/news-media/video-gallery/revolutionary-advances-in-cancer-treatment-memorial-sloan-kettering-cancer-center-and-the-weizmann-institute-of-science/

Nov 21, 2019... Dr. Jonathan Coleman, MD, Memorial Sloan Kettering Cancer Research Center, and Prof. Avigdor Scherz, Weizmann Institute of Science, discuss ongoing clinical trials at MSKCC testing vascular targeted photodynamic therapy for prostate cancer. Developed at the Weizmann Institute, this revolutionary treatment uses light emitted by optical fibers that are inserted into the prostate (and possibly other areas), activating a drug that destroys cancer cells—with little side effects.

TAGS: Cancer

Weizmann in Focus, Episode 7: Stopping a Deadly Skin Cancer
Weizmann in Focus, Episode 7: Stopping a Deadly Skin Cancer

https://weizmann-usa.org/news-media/video-gallery/weizmann-in-focus-episode-7-stopping-a-deadly-skin-cancer/

Jul 16, 2019... Summer is here! But more fun in the sun also increases our risk for skin cancer, including its deadliest form, melanoma. In the seventh episode of Weizmann in Focus, CEO Dave Doneson highlights a melanoma research breakthrough by Prof. Yardena Samuels, which could lead to “the ultimate personalized cancer therapy.”

TAGS: Community, Cancer, Cancer treatment, Philanthropy, Leadership, Immunotherapy

October is National Breast Cancer Awareness Month
October is National Breast Cancer Awareness Month

https://weizmann-usa.org/news-media/feature-stories/october-is-national-breast-cancer-awareness-month-1/

Oct 16, 2019... October is National Breast Cancer Awareness Month, and people across the world are helping raise awareness and support through runs, walks, events – and, at the Weizmann Institute of Science, through research.
Before breakthroughs in breast cancer research ever appear in the news or on the market, there are cadres of scientists working tirelessly to discover new ways to prevent, diagnose, and treat this all-too-common disease. Here are some of our advances over just the past year:

TAGS: Women, Cancer, Biology, Cancer treatment

Predicting Immunotherapy Success
Predicting Immunotherapy Success

https://weizmann-usa.org/news-media/news-releases/predicting-immunotherapy-success/

Feb 18, 2020... REHOVOT, ISRAEL—February 18, 2020—One of the frustrations with anti-cancer therapy is that no one drug fits all: Most work well in some people but have little effect in other patients with the same type of cancer. This is as true of the newer immunotherapy treatments as it is of older types of chemotherapy. Weizmann Institute of Science researchers have now identified new markers that can help predict which patients have a better chance for a positive response to immunotherapy treatments. Their findings were reported in Nature Communications.

TAGS: Cancer, Biology, Cancer treatment, Immunotherapy

Cell Diversity May Explain Why a Brain Cancer is Hard to Treat
Cell Diversity May Explain Why a Brain Cancer is Hard to Treat

https://weizmann-usa.org/news-media/in-the-news/cell-diversity-may-explain-why-a-brain-cancer-is-hard-to-treat/

Sep 27, 2019... Glioblastoma, a typically incurable brain cancer, is a master of diversity. Not only do the tumors differ from one patient to the next, but cells within each tumor differ greatly from one another. In a study published recently in Cell, researchers at the Weizmann Institute of Science, working in collaboration with Boston researchers and physicians, have found that glioblastoma cells come in as many as four “states,” or subtypes, and – as if that were not enough – these cells can transition from one state to another. These findings might help explain why glioblastoma is so difficult to treat and point toward ways of developing future therapies.

TAGS: Brain, Cancer, Molecular genetics

Neuroendocrine Tumor Research Foundation Awards $3.5 Million in Grants
Neuroendocrine Tumor Research Foundation Awards $3.5 Million in Grants

https://weizmann-usa.org/news-media/in-the-news/neuroendocrine-tumor-research-foundation-awards-3-5-million-in-grants/

Feb 25, 2020... After investing $26 million in research during the past 15 years, NETRF has helped to establish the NET knowledge base needed to expand the exploration of improved treatments, according to Elyse Gellerman, NETRF Chief Executive Officer. “We can see real momentum in this new round of grants. We hope the discoveries from these projects will lead to improved treatment options for patients.”
NETRF is supporting a new pioneering approach to NET immunotherapy with a Petersen Accelerator Award to Steven Libutti, MD, Rutgers Cancer Institute of New Jersey,  to characterize a novel immune regulator called B7x to determine whether it has a role in shutting off the body’s immune response to fight against pancreatic NETs.

TAGS: Awards, Neuroscience, Cancer, Central nervous system

Cell Diversity in Tumors Prevents Effective Immune Responses
Cell Diversity in Tumors Prevents Effective Immune Responses

https://weizmann-usa.org/news-media/in-the-news/cell-diversity-in-tumors-prevents-effective-immune-responses-study/

Sep 13, 2019... Illustrative photo of a doctor with a cancer patient (via Shutterstock)
Researchers at the Weizmann Institute of Science have found that diversity in cancer cells causes the cancers to be less responsive to immunotherapies — treatments that harness the immune system to tackle the devastating disease.
The Weizmann researchers say their findings indicate that heterogeneity of the cancer cells should be taken into account when trying to understand whether a patient will benefit from immunotherapies.

TAGS: Cancer, Biology, Immunotherapy

First 1 2 3 Last
Next
SHARE

Our Achievements

Learn more about remarkable Weizmann Institute achievements that are enhancing and transforming our lives.

Learn More

Support Our Flagship Projects

Help us accelerate exciting initiatives in three forward-looking fields: neuroscience, physics, and artificial intelligence.

Learn More

Newsletter

Get the latest news and breakthroughs from the Weizmann Institute of Science.

About Us
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
  • WeizmannNow
Our Achievements
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Get Involved
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
News & Media Blog: Curiosity Review Fighting Coronavirus Donate Now Contact Us
Privacy Policy Gift Acceptance Policy Financial Information

©2022 American Committee for the Weizmann Institute of Science

Charity Navigator

FOR THE FOURTH CONSECUTIVE YEAR